Skip to main content

Table 2 Disease status before initiation of trastuzumab treatment

From: Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry

Characteristics

Number

%

Age (years)

  

 Median (Range)

58.5 (31–86)

 

BMI (kg/m2)

  

 Median (Range)

25.1 (16–50)

6.3

 <18

16

42.2

 18–25

108

51.5

 >25

132

 

ECOG performance status

  

 0

115

49.8

 1

108

46.8

 2

8

3.4

Disease-free survival (months)

  

 Median (Range)

37.3 (1–413)

 

Site of disease recurrence

  

 Inoperable locoregional recurrence

41

15.3

 Metastatic disease

140

52.2

 Both

87

32.5

Site of locoregional recurrence

  

 Breast

47

17.5

 Axillary lymph nodes

64

23.9

 Supraclavicular lymph nodes

33

12.3

 Chest wall

23

8.6

 not specified

15

5.6

Site of metastatic disease

  

 Lung

75

28.0

 Liver

88

32.8

 Bone

102

38.1

 CNS

6

2.2

 Other

25

9.3